Biogen shares surge 38% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

June 7, 2021 admin National Comments Off on Biogen shares surge 38% after FDA approves Alzheimer’s drug, the first new therapy for the disease in nearly two decades

Visits: 0

The drug, which is marketed under the name Aduhelm, is expected to generate billions of dollars in revenue for the company. Read More Go To Source